Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2018201720162015201420132012201120102009200820072006 Nektar to Hold Investor & Analyst Event at 2016 Society for Immunotherapy of Cancer Annual Meeting Oct 28, 2016 Nektar Therapeutics Announces Upcoming Presentations at the 2016 Society for Immunotherapy of Cancer Annual Meeting Oct 28, 2016 Nektar to Announce Financial Results for the Third Quarter 2016 on Thursday, November 3, 2016, After Close of U.S.-Based Financial Markets Oct 27, 2016 Nektar Therapeutics Prices Public Offering of Shares of Common Stock Oct 19, 2016 Nektar Therapeutics Announces Public Offering of Shares of Common Stock Oct 17, 2016 Nektar Therapeutics to Host Investor & Analyst Conference Call to Discuss New Clinical Collaboration with Bristol-Myers Squibb Sep 27, 2016 Bristol-Myers Squibb and Nektar Therapeutics Announce Oncology Clinical Collaboration to Evaluate the Combination of Opdivo (nivolumab) and NKTR-214 Sep 27, 2016 Nektar Therapeutics Reports Financial Results for the Second Quarter of 2016 Aug 03, 2016 Nektar to Announce Financial Results for the Second Quarter 2016 on Wednesday, August 3, 2016, After Close of U.S.-Based Financial Markets Jul 27, 2016 Preclinical Data Presented at ASCO 2016 Annual Meeting Demonstrate that Single-Agent NKTR-214 Produces a Large Increase in Tumor-Infiltrating Lymphocytes to Provide Durable Anti-Tumor Activity Jun 06, 2016 Pagination First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page next › Last page last »